FDA clears Bio­gen, Sage's pill for post­par­tum de­pres­sion; What will Roivant, Bridge­Bio do next?; EQRx be­comes his­to­ry; Non-opi­oid pain drugs face piv­otal mo­ment; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

On Sep­tem­ber 20, we will be host­ing an awards gala in Boston for this year’s End­points 11, a group of the most promis­ing biotechs in the glob­al in­dus­try as se­lect­ed by an End­points team led by founder John Car­roll. Join us for an evening of din­ner, drinks and net­work­ing to meet the fu­ture of biotech. You can learn more de­tails and re­serve your seats here.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.